Results 61 to 70 of about 1,642,043 (400)
Techniques for Identification of Left Ventricular Asynchrony for Cardiac Resynchronization Therapy in Heart Failure [PDF]
The most recent treatment option of medically refractory heart failure includes cardiac resynchronization therapy (CRT) by biventricular pacing in selected patients in NYHA functional class III or IV heart failure. The widely used marker to indicate left
Peter, Schuster, Svein, Faerestrand
core
Self‐Assembling Multi‐Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma
A novel modular T‐cell engager platform, MATCH, is developed for personalized multiple myeloma therapy. MATCH uses complementary oligonucleotide‐linked Fab’ fragments to enable flexible targeting of MM antigens and controlled T‐cell activation. The system shows potent, antigen‐specific cytotoxicity in vitro and in vivo, highlighting its potential for ...
Shannuo Li +8 more
wiley +1 more source
Cardiac resynchronization therapy in heart failure – Beyond the standard
Cardiac resynchronization therapy device (CRT- defibrillator and CRT-pacemaker) implantations have increased remarkably over the last decade. Conventionally these devices are used in patients with symptomatic systolic left ventricular (LV) dysfunction ...
Soumen Devidutta, Calambur Narasimhan
doaj +1 more source
Background: Accelerated ventricular response is frequently observed during radiofrequency ablation (RFA) of premature ventricular complexes (PVCs). We hypothesized that acceleration indicates an appropriate site and adequate injury to the arrhythmogenic ...
Sirish Chandra Srinath Patloori +3 more
doaj +1 more source
BackgroundNew technologies for ablation procedures are often produced by different companies with no cross-compatibility out of the box. This is not a negligible clinical problem since those separately developed devices are often used together.
Luigi Pannone +17 more
doaj +1 more source
Biodegradable Implantable Electronics with Wireless Technology for Real‐Time Clinical Applications
The article explores how bioresorbable implantable electronics merge wireless communication and power delivery with biodegradable materials to enable real‐time clinical applications. It highlights advances in materials, system design, and medical uses across neural, cardiovascular, digestive, immune, and drug‐delivery systems.
Myeongki Cho +4 more
wiley +1 more source
This study presents an implantable reinforced cardiac patch (RCPatch) combining volumetrically 3D‐printed metamaterials with melt‐electrowritten (MEW) meshes. The design integrates tunable stiff polymer structures with soft, cell‐laden hydrogels. The RCPatch withstands suturing, intraventricular pressure, and cardiac contraction in a large animal ...
Lewis S. Jones +12 more
wiley +1 more source
Galvanic‐Cell‐Based Self‐Powered Bioelectronic Devices
The emerging galvanic‐cell‐based self‐powered bioelectronics for biomedical applications with passive and active control strategies are summarized. In addition, the challenges and opportunities for galvanic devices are also discussed. Abstract Bioelectronic devices hold significant promise for advancing biomedical technologies, addressing critical ...
Yu Xin +4 more
wiley +1 more source
An ideal implant should mimic native tissues such that it can integrate, sense, heal, and continue to function, i.e., be autonomous. Although early, there are good steps taken in this way, e.g., the development of stimuli‐responsive, self‐powering, self‐actuating, self‐healing, self‐regenerating, and self‐aware implants.
Jagan Mohan Dodda +5 more
wiley +1 more source
This study presents a novel 4D bioprinting technique for fabricating cardiac tissues with complex microvasculature. Unlike traditional 3D printing, it enables capillary‐scale structure formation via selective post‐printing shrinkage. This approach overcomes resolution limits of printing cell‐laden hydrogels, allowing the creation of functional ...
Ester Sapir Baruch +6 more
wiley +1 more source

